The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.
At 47 years of age, Emi Bossio was feeling good about where she was. She had a successful law practice, two growing children and good health. Then she developed a nagging cough. The diagnosis to come ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for ...
Eating more fruit could help protect lungs from air pollution damage, particularly in women. Researchers point to antioxidants and anti-inflammatory compounds in fruit as possible defenses against ...
Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, ...
A man who vaped for nearly a decade is urging young people to quit after his lung suddenly collapsed. Raymond Dehn, 24, had been vaping since the age of 15 — after sneaking devices from a local shop ...
Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, ...
If you’re looking to reduce your chances of developing lung disease, say experts at UC San Francisco, then it may be smart to avoid inhaling cannabis. A new study in the Journal of General Internal ...
AURORA, Colo. (KDVR) — Dr. Ross Camidge is the director of the Thoracic Oncology Department at the University of Colorado Cancer Center on the Anschutz Medical Campus. “We’ve led or contributed to ...
Third Person Shooters How to kill a Hive Lord in Helldivers 2 Third Person Shooters Helldivers 2 players are down but not out – the new Hive Lords can apparently eat 15 Hellbombs before finally going ...
Sept 2 (Reuters) - Shares of United Therapeutics (UTHR.O), opens new tab surged 37% to an all-time high on Tuesday after its drug Tyvaso significantly improved lung function in patients with a ...
United Therapeutics is making headway in unlocking a new lung disease market for its drug Tyvaso (treprostinil) with a pivotal phase 3 win in idiopathic pulmonary fibrosis (IPF). United’s Teton-2 ...